切换至 "中华医学电子期刊资源库"

中华腔镜泌尿外科杂志(电子版) ›› 2025, Vol. 19 ›› Issue (06) : 792 -795. doi: 10.3877/cma.j.issn.1674-3253.2025.06.017

综述

经皮肾镜碎石取石术后肾功能恶化的围术期影响因素研究进展
周福安, 陈戬()   
  1. 650000 云南,昆明医科大学第二附属医院泌尿外科
  • 收稿日期:2024-01-26 出版日期:2025-12-01
  • 通信作者: 陈戬

Research progress on perioperative influencing factors of renal function deterioration after percutaneous nephrolithotomy

Fu'an Zhou, Jian Chen()   

  1. Department of Urology, Second Affiliated Hospital of Kunming Medical University, Kunming 650000, China
  • Received:2024-01-26 Published:2025-12-01
  • Corresponding author: Jian Chen
引用本文:

周福安, 陈戬. 经皮肾镜碎石取石术后肾功能恶化的围术期影响因素研究进展[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(06): 792-795.

Fu'an Zhou, Jian Chen. Research progress on perioperative influencing factors of renal function deterioration after percutaneous nephrolithotomy[J/OL]. Chinese Journal of Endourology(Electronic Edition), 2025, 19(06): 792-795.

经皮肾镜碎石取石术在治疗上尿路结石中占有重要地位,随着技术的不断发展,越来越多的学者开始关注经皮肾镜碎石取石术后肾功能恶化的影响因素,包括术前影响因素:尿路感染、高血压、糖尿病、蛋白尿、血清肌酐等;术中影响因素:通道大小、通道数量、手术时间、术中低血压等;术后影响因素:出血等。本文对PCNL术后肾功能恶化的围术期影响因素相关研究进展进行综述,以期为临床预防和减少术后肾功能恶化提供参考依据。

Percutaneous nephrolithotomy plays an important role in the treatment of upper urinary tract calculi. With the continuous development of technology, more and more scholars begin to pay attention to the influencing factors of renal function deterioration after percutaneous nephrolithotomy, including preoperative influencing factors: urinary tract infection, hypertension, diabetes, proteinuria, serum creatinine, etc; intraoperative influencing factors: channel size, number of channels, surgical time, intraoperative hypotension, etc; postoperative influencing factors: bleeding, etc. This review synthesizes current evidence on perioperative determinants of renal function deterioration after PCNL, aiming to provide guidance for clinical prevention and management of this complication.

[1]
Skolarikos A, Jung H, Neisius A, et al. EAU Guidelines on Urolithiasis 2025[EB/OL].

URL    
[2]
王明瑞, 王起, 胡浩, 等. 标准通道经皮肾镜取石术治疗孤立肾肾结石的长期安全性和有效性[J]. 北京大学学报(医学版), 2020, 52(4): 663-666. DOI: 10.19723/j.issn.1671-167X.2020.04.012.
[3]
Jung JH, Yoo S, Park J, et al. Postoperative renal functional changes assessed by 99mTc-DTPA scintigraphy and predictive factors after miniaturized percutaneous nephrolithotomy and retrograde intrarenal surgery: an observational 1-year follow-up study[J]. Investig Clin Urol, 2020, 61(1): 59-66. DOI: 10.4111/icu.2020.61.1.59.
[4]
Xiao Y, Li Q, Huang C, et al. Perioperative and long-term results of retroperitoneal laparoscopic pyelolithotomy versus percutaneous nephrolithotomy for staghorn calculi: a single-center randomized controlled trial[J]. World J Urol, 2019, 37(7): 1441-1447. DOI: 10.1007/s00345-018-2526-x.
[5]
Akman T, Binbay M, Kezer C, et al. Factors affecting kidney function and stone recurrence rate after percutaneous nephrolithotomy for staghorn calculi: outcomes of a long-term followup[J]. J Urol, 2012, 187(5): 1656-1661. DOI: 10.1016/j.juro.2011.12.061.
[6]
黄春泉, 安凌春, 于世超, 等. 孤立肾结石患者经皮肾镜取石术后的肾功能变化及围手术期风险因素研究[J]. 新疆医科大学学报, 2017, 40(8): 1020-1024. DOI: 10.3969/j.issn.1009-5551.2017.08.009.
[7]
Wang J, Bai Y, Yin S, et al. Risk factors for deterioration of renal function after percutaneous nephrolithotomy in solitary kidney patients with staghorn calculi[J]. Transl Androl Urol, 2020, 9(5): 2022-2030. DOI: 10.21037/tau-20-916.
[8]
Huang J, Zhang S, Huang Y, et al. Is multiple tract percutaneous nephrolithotomy a safe approach for staghorn calculi?[J]. World J Urol, 2021, 39(6): 2121-2127. DOI: 10.1007/s00345-020-03420-8.
[9]
Cui J, Wang J, Bai Y, et al. Short-term alteration of renal function after percutaneous nephrolithotomy in solitary kidney patients with staghorn calculi: a single-center experience[J]. Asian J Surg, 2021, 44(12): 1625-1626. DOI: 10.1016/j.asjsur.2021.08.033.
[10]
Cooke JP. Inflammation and its role in regeneration and repair[J]. Circ Res, 2019, 124(8): 1166-1168. DOI: 10.1161/CIRCRESAHA.118.314669.
[11]
Simonetti O, Lucarini G, Morroni G, et al. New evidence and insights on dalbavancin and wound healing in a mouse model of skin infection[J]. Antimicrob Agents Chemother, 2020, 64(4): e02062-19. DOI: 10.1128/AAC.02062-19.
[12]
张爱平, 罗生军, 周江涛, 等. 经皮肾镜碎石术后急性肾损伤的危险因素分析及防治[J]. 重庆医科大学学报, 2025, 50(2): 191-197. DOI: 10.13406/j.cnki.cyxb.003714.
[13]
Fayad AS, Elsheikh MG, Mosharafa A, et al. Effect of multiple access tracts during percutaneous nephrolithotomy on renal function: evaluation of risk factors for renal function deterioration[J]. J Endourol, 2014, 28(7): 775-779. DOI: 10.1089/end.2013.0771.
[14]
Choy SH, Nyanatay SA, Sothilingam S, et al. Cardiovascular risk factors, ethnicity and infection stone are independent factors associated with reduced renal function in renal stone formers[J]. PLoS One, 2022, 17(4): e0265510. DOI: 10.1371/journal.pone.0265510.
[15]
崔方强, 赵文景. 高血压肾损害诊疗进展[J]. 中国继续医学教育, 2020, 12(2): 113-116. DOI: 10.3969/j.issn.1674-9308.2020.02.048.
[16]
索斌诚. 高血压肾损害临床治疗新进展[J]. 中外医学研究, 2021, 19(3): 194-196. DOI: 10.14033/j.cnki.cfmr.2021.03.072.
[17]
Yadav R, Agarwal S, Sankhwar S, et al. A prospective study evaluating impact on renal function following percutaneous nephrolithotomy using Tc99m ethylenedicysteine renal scan: Does multiplicity of access tracts play a role?[J]. Investig Clin Urol, 2019, 60(1): 21-28. DOI: 10.4111/icu.2019.60.1.21.
[18]
Mercimek MN, Ender O. Effect of urinary stone disease and its treatment on renal function[J]. World J Nephrol, 2015, 4(2): 271-276. DOI: 10.5527/wjn.v4.i2.271.
[19]
Kuzgunbay B, Gul U, Turunc T, et al. Long-term renal function and stone recurrence after percutaneous nephrolithotomy in patients with renal insufficiency[J]. J Endourol, 2010, 24(2): 305-308. DOI: 10.1089/end.2009.0362.
[20]
白维斌, 王永堂. 多通道经皮肾镜取石术对肾功能的影响及肾功能减退的危险因素分析[J]. 现代泌尿外科杂志, 2016, 21(9): 691-693, 699. DOI: 10.3969/j.issn.1009-8291.2016.09.010.
[21]
刘振文, 谭谡, 王元林, 等. 标准通道与微创经皮肾镜取石术对患肾功能影响的临床初步研究[J]. 求医问药(学术版), 2012, 10(11): 691-692, 1063.
[22]
王世伟, 徐雪峰, 赵学良, 等. 三种微创术式治疗输尿管上段复杂性结石疗效及对肾功能、术后疼痛的影响[J]. 西部医学, 2023, 35(2): 238-241, 246. DOI: 10.3969/j.issn.1672-3511.2023.02.016.
[23]
Izol V, Deger M, Akdogan N, et al. The effect of percutaneous nephrolithotomy on the estimated glomerular filtration rate in patients with chronic kidney disease[J]. J Endourol, 2021, 35(5): 583-588. DOI: 10.1089/end.2020.0512.
[24]
Wang Z, Feng D, Cao D, et al. Comparison of safety and efficacy between single-tract and multiple-tract percutaneous nephrolithotomy treatment of complex renal calculi: a systematic review and meta-analysis[J]. Minerva Urol Nephrol, 2021, 73(6): 731-738. DOI: 10.23736/S2724-6051.21.04239-9.
[25]
Reeves T, Pietropaolo A, Gadzhiev N, et al. Role of endourological procedures (PCNL and URS) on renal function: a systematic review[J]. Curr Urol Rep, 2020, 21(5): 21. DOI: 10.1007/s11934-020-00973-4.
[26]
El-Nahas AR, Nabeeh MA, Laymon M, et al. Preoperative risk factors for complications of percutaneous nephrolithotomy[J]. Urolithiasis, 2021, 49(2): 153-160. DOI: 10.1007/s00240-020-01203-9.
[27]
El-Tabey NA, El-Nahas AR, Eraky I, et al. Long-term functional outcome of percutaneous nephrolithotomy in solitary kidney[J]. Urology, 2014, 83(5): 1011-1015. DOI: 10.1016/j.urology.2013.12.025.
[1] 张勇, 巴特, 张倞, 刘玲英. 基于肠道-器官轴的烧伤并发症的研究进展[J/OL]. 中华损伤与修复杂志(电子版), 2025, 20(05): 452-457.
[2] 钱龙, 蔡大明, 王行舟, 艾世超, 胡琼源, 孙锋, 宋鹏, 王峰, 王萌, 陆晓峰, 朱欢欢, 沈晓菲, 管文贤. 局部不可切除胃癌转化治疗(联合免疫治疗)后淋巴结转移的相关危险因素分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(06): 624-627.
[3] 周丽君, 李姣姣, 孙燕, 王露, 钱蓉. 不同吻合方式对腹腔镜辅助远端胃癌根治术患者术后恢复的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(06): 642-645.
[4] 王毅, 孔剑桥, 张鹏, 代扬, 李恒平. 腹腔镜超声引导十二指肠镜治疗胆囊合并胆总管结石[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(06): 658-661.
[5] 马超, 王传嘉, 张武坊. 经腋窝入路单孔腔镜保乳术与传统开放手术治疗早期乳腺癌的对比研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(06): 674-677.
[6] 张超, 常剑. 混合入路与中间入路行腹腔镜右半结肠癌根治术的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(06): 685-688.
[7] 陈系东, 王绍闯, 赵何伟, 王硕, 袁维栋. 高龄BCLC B期肝癌患者常规TACE术后急性肝功能恶化的危险因素研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(06): 689-692.
[8] 程必盛, 吴芃. 2025EAU年会要点:微创、远程与精准泌尿外科的发展趋势[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(06): 693-699.
[9] 谷瑞辰, 林福杨, 刘永达. 术前尿培养阴性患者PCNL术后尿路感染的预测模型构建[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(06): 772-777.
[10] 陈宁, 赵欣, 周园, 刘兵, 窦进, 王健, 张晓雨, 赵海剑. 预测绞窄性与非绞窄性腹股沟嵌顿疝:一项基于多变量逻辑回归的预测模型研究[J/OL]. 中华疝和腹壁外科杂志(电子版), 2025, 19(05): 539-543.
[11] 高瞻, 唐莎莎, 秦蘅, 王关嵩, 张雯. 慢性阻塞性肺疾病合并肺癌的临床特征及危险因素分析[J/OL]. 中华肺部疾病杂志(电子版), 2025, 18(05): 685-690.
[12] 许猛军, 王泽贤, 郭亚茹, 董海北, 刘欢欢, 史凌云, 郭雯, 刘枫, 吴小进, 曹爱红. CT定位下经皮肺穿刺活检术在肺部肿瘤患者中的应用[J/OL]. 中华肺部疾病杂志(电子版), 2025, 18(05): 752-756.
[13] 曾锐. 抑制急性肾损伤向慢性肾脏病转化:靶向致病性肾脏巨噬细胞纳米药物的应用[J/OL]. 中华肾病研究电子杂志, 2025, 14(05): 241-247.
[14] 姜彤彤, 戎萍, 马融, 付乾芳, 张亚同, 赵书艺, 刘晖, 马榕, 李悦, 李瑞本. 抽动障碍儿童呼吸道感染后的临床特征及抽动症状加重的危险因素分析[J/OL]. 中华临床医师杂志(电子版), 2025, 19(06): 426-432.
[15] 再米拉·依力哈木, 蒋升, 艾比拜·玉素甫. SGLT2抑制剂与肾结石风险:一项荟萃分析[J/OL]. 中华临床医师杂志(电子版), 2025, 19(06): 446-453.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?